Psychiatry

Lithium: Could This Common Drug Offer Hope for Autism Spectrum Disorder? A groundbreaking study from the Institute for Basic Science (IBS) has revealed a potential new treatment avenue for autism …

This is a large language models. I will attempt to Frailty and depression:

New Research Links GLP-1 RA Use to Reduced Stroke Risk in Type 2 Diabetes Patients Rushad Patell, MDCredit: BIDMC A recent study published at the 66th American Society of Hematology …

Henning Bliddal, MD, MSci Credit: The Parker Institute Semaglutide Shows Promise in Reducing Knee Osteoarthritis Pain in Obese Individuals In a groundbreaking study, semaglutide, a medication primarily known for its …

New Hope for IgA Nephropathy: Promising Treatment Advancements The landscape of IgA nephropathy (IgAN) management is experiencing a remarkable transformation. Driven by decades of research unraveling the disease’s intricate pathophysiology, …

Lean Liver Disease: A Hidden Threat Affecting Millions of Americans New research is shining a light on a concerning trend: lean metabolic dysfunction-associated steatotic liver disease (MASLD) is affecting a …

Semaglutide Shows Promise for Non-Diabetic Chronic Kidney Disease in Landmark SMART Trial Exciting news emerged from Kidney Week 2024 as the landmark SMART trial unveiled promising results for semaglutide (Ozempic/Wegovy) …

Semaglutide Shows Promise in Reducing Cardiovascular and All-Cause Mortality in Patients with Type 2 Diabetes and CKD New data from the FLOW trial, presented at the American Society of Nephrology’s …

Hiddo Heerspink, PharmD, PhDCredit: George Institute for Global Health Semaglutide Shows Promise in Managing Chronic Kidney Disease Without Diabetes A recent clinical trial suggests semaglutide (Ozempic) may hold significant potential …

Will Herrington, MA, MBBS, MD, FRCP, FERA Credit: Oxford University Empagliflozin Continues to Protect Kidney Health After Trial Completion New data from the EMPA-KIDNEY trial presented at ASN Kidney Week …